Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer

BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors prevent cell growth and have shown benefit in the treatment of metastatic colorectal cancer, whether used as single agents or in combination with chemotherapy. Clear benefit has been shown in trials of EGFR monoclonal antibodies (EGFR MA...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Chan, David Lok Hang, Segelov, Eva, Wong, Rachel SH, Smith, Annabel, Herbertson, Rebecca A, Li, Bob T., Tebbutt, Niall, Price, Timothy, Pavlakis, Nick
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2017
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6481896/
https://ncbi.nlm.nih.gov/pubmed/28654140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007047.pub2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky